edoxaban

Ukraine

Drugs containing this active substance

  • EDOXACORD

    The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 15 mg

    ATC: B01AF03

    Manufacturer: JSC "Kyiv Vitamin Plant"

  • The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 30 mg

    ATC: B01AF03

    Manufacturer: JSC "Kyiv Vitamin Plant"

  • The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 60 mg

    ATC: B01AF03

    Manufacturer: JSC "Kyiv Vitamin Plant"

  • The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 30 mg

    ATC: B01AF03

    Manufacturer: Pharos MT Limited (production of finished product, primary and secondary packaging, batch control, batch release)

  • The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    edoxaban 60 mg

    ATC: B01AF03

    Manufacturer: Pharos MT Limited (production of finished product, primary and secondary packaging, batch control, batch release)